On 9 November 2017, the Chamber of Representatives approved the draft law implementing MiFID II into Belgian law.
The draft law is now available on the Chamber’s website.
For more information on this major subject, please do not hesitate to contact our team.
A new Belgian Companies’ code is under preparation. It aims at modernizing the regime applicable to companies and associations.
One of the four legal scholars chosen as experts by the Minister of Justice Koen Geens to work on this project is Paul Alain Foriers. Hence, Simont Braun is well aware of what is to expect and when, and is able to guide companies through the upcoming challenges and opportunities.
Le Code des Impôts sur les Revenus (ci-après « CIR/92 ») prévoit, à certaines conditions, un régime fiscal favorable pour les revenus des personnes physiques en cas de cession ou concession de droits d’auteur.
Dans ce contexte, Simont Braun a récemment assisté un de ses clients en vue d’obtenir une décision anticipée en matière fiscale (dite « ruling ») auprès du Service des Décisions Anticipées (ci-après « SDA ») qui a fait une analyse complète, mais nuancée de ce régime fiscal.
A RISK-BASED APPROACH, YOU SAID?
In Le Soir of 27 July 2017, Philippe Campolini and Gaëtan Goossens comment on the implications of Data Protection Law and the upcoming GDPR when the manufacturers of electronic home appliances intend to sell the data collected through these devices to companies like Amazon, Google or Apple, to enable them to personalize shopping offers.
A few years ago, many were shocked by the news that thousands of women across the world suffered harm caused by wrongly manufactured breast implants. For several years a French manufacturer had used industrial silicone instead of medical grade silicone to produce breast implants, in violation of the approval that had been issued by the notified body. Furthermore, a BBC investigation revealed that hundreds of thousands of individuals across the world could have been exposed to dangerously high levels of toxic metals from failing hip implants.
These revelations were some of the reasons why the European Commission issued, on 26 September 2012, two new regulation proposals to replace the three existing medical devices directives. One of the proposed regulations concerned in vitro diagnostic medical devices only, while the other one related to all other sorts of medical devices. These proposals marked the beginning of a long legislative process that led to the renewal of the regulatory framework on medical devices.
On 5 April 2017, the regulation on medical devices (hereinafter “MDR”) and the regulation on in vitro diagnostic medical devices (hereinafter “IVDR”) were adopted. They were published on 5 May 2017 and entered into force on 25 May 2017. The MDR will apply from 26 May 2020 and the IVDR from 26 May 2022.
Un nouveau règlement européen relatif aux procédures d’insolvabilité est entré en vigueur le 26 juin 2015. Il remplacera le règlement n° 1346/2000 à partir du 26 juin 2017.